Clinical Trials
2 trialsNCT01962987 2020-07-20
A Study Comparing Diclofenac Sodium Gel 3% to SolarazeĀ® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis
Actavis Inc.
Phase 3 Completed
NCT00601640 2017-03-23
Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin
University of Arizona
Phase 2 Completed